MIFH
BPMC

Migdal Insurance & Financial Holdings’s Blueprint Medicines BPMC Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,758
Closed -$657K – 595
2021
Q1 		$657K Buy
6,758
+4,194
+164% +$419K 0.01% 291
2020
Q4 		$288K Buy
+2,564
New +$270K ﹤0.01% 268

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Migdal Insurance & Financial Holdings's BPMC Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Blueprint Medicines (BPMC) in Q2 2021, closing a stake of 6,758 shares — an estimated $657K sold.

Migdal Insurance & Financial Holdings first reported a position in BPMC in Q4 2020 and held it in 2 quarters. The position peaked at $657K in Q1 2021. 281 funds tracked by Wall St. Rank hold BPMC as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining Blueprint Medicines position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 6,758 Blueprint Medicines shares in Q2 2021, an estimated $657K.
  • Migdal Insurance & Financial Holdings first reported a position in Blueprint Medicines in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Blueprint Medicines position peaked at $657K in Q1 2021.
  • 281 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.